Replies to post #75281 on $heff's $tation of $tocks & $olid DD

[$heff]

LJPC..$.158..Remember the Phase 2 catalyst for April. It will be here in no time and it is a strong catalyst for the company.

La Jolla Pharmaceutical Company Announces Complete Enrollment of Phase 2 Clinical Trial of GCS-100 in Chronic Kidney Disease - http://yhoo.it/1d6bR6C
Announced that it has completed enrollment of its placebo-controlled, randomized Phase 2 clinical trial of GCS-100 in patients with chronic kidney disease ("CKD"). A total of 121 patients with Stage 3b or 4 CKD were enrolled in the study. The Company expects to announce data on the primary endpoint in April 2014 and the full data package before the end of the second quarter 2014.